European Commission call for data on Cannabidiol (CBD)
Ingredients: CANNABIDIOL (CBD)

Date of publication: 01/06/2023

the European Commission launched a call for data on the safety of Cannabidiol (CBD) in pure form, as well as an extract that may contain contaminants of other cannabinoids, including THC at trace levels.

Background

Cannabidiol (CBD) (CAS No. 13956-29-1, EC No. 689-176-3) with the chemical name ‘2-[(6R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol’ is included in the European database for information on cosmetic substances and ingredients (CosIng) with the reported functions of ‘skin conditioning’, ‘skin protecting’, ‘antioxidant’, ‘anti-sebum’, etc.

Currently, CBD as such is not regulated under EU Cosmetics Regulation (EC) No 1223/2009. However, entry 306 of Annex II to the EU Cosmetics Regulation prohibits ‘Narcotics, natural and synthetic: All substances listed in Tables I and II of the Single Convention on narcotic drugs signed in New York on 30 March 1961’ for use in cosmetic products.

On 19 November 2020, the Court of Justice of the EU (CJEU) delivered a judgment in Case C-
663/185 concerning the legal status of cannabidiol. In the judgement, the CJEU concluded that
CBD at stake in the main proceedings, should not be considered as a drug under the UN Single
Convention on Narcotic Drugs of 1961.

What’s new?

On 1 June 2023, the European Commission launched a call for data on the safety of Cannabidiol (CBD) (CAS No. 13956-29-1, EC No. 689-176-3) in pure form, as well as an extract that may contain contaminants of other cannabinoids, including trans-Δ⁹-tetrahydrocannabinol (THC or delta-9-THC) (CAS No. 1972-08-3, EC No. 625-153-6), at trace levels.

Considering the very limited available information regarding the safety of CBD in cosmetic
products, the main objective of this call is to gather relevant scientific information to enable the Scientific Committee on Consumer Safety (SCCS) to perform a safety assessment.

Any interested parties, including academic and other research institutes, EU countries’ authorities, manufacturers of cosmetic products, producers of Cannabidiol (CBD) and consumers associations, are invited by the European Commission to submit any relevant scientific information.

Period of consultation: from 1 June 2023 to 30 September 2024 (15 months)

References:

European Commission – Call for data on ingredients used in cosmetic products

Linkedin Instagram Facebook

other REGULATORY UPDATES

Regulation (EU) 2022/1531 – OMNIBUS ACT V – applicable as of 17 December 2022

Ingredients: METHYL SALICYLATE, SODIUM HYDROXYMETHYLGLYCINATE, DBMC, MIBK

Date of publication: 15/09/2022

Date of application: 17/12/2022

The European Commission has published the Commission Regulation (EU) 2022/1531, which amends the Regulation (EC) No 1223/2009 as regards the use in cosmetic products of certain substances classified as CMR, by adding new entries to Annex II and Annex III and revising an entry in Annex V.

Read More »

UK Responsible Person Labelling Deadline Extension

RESPONSIBLE PERSON

Date of application: 31/12/2025

The UK Office for Product Safety and Standards (OPSS) have reviewed the requirement to label the product with the UK Responsible Person and have decided to extend this transitional provision for a total period of five years, until 31 December 2025.

Read More »

SCCS Revision of the Scientific Opinion on Vitamin A

Ingredients: RETINOL, RETINYL PALMITATE, RETINYL ACETATE, RETINYL LINOLEATE, RETINAL

Date of publication: 25/10/2022

The Scientific Committee on Consumer Safety has issued a final version of the Scientific Opinion on Vitamin A, concluding that exposure to Vitamin A derived from cosmetics can be a concern for higher exposure consumers, and since cosmetics alone do not exceed the upper limit the SCCS cannot suggest maximum concentration limits that take into account contributions from other sources.

Read More »
Any REGULATORY QUESTION?
E-mail

SCCS Revision of the Scientific Opinion on Vitamin A

Ingredients: RETINOL, RETINYL PALMITATE, RETINYL ACETATE, RETINYL LINOLEATE, RETINAL

Date of publication: 25/10/2022

The Scientific Committee on Consumer Safety has issued a final version of the Scientific Opinion on Vitamin A, concluding that exposure to Vitamin A derived from cosmetics can be a concern for higher exposure consumers, and since cosmetics alone do not exceed the upper limit the SCCS cannot suggest maximum concentration limits that take into account contributions from other sources.

Read More »

SCCS Final Opinion on the Safety of Triclocarban and Triclosan

Ingredients: TRICLOCARBAN and TRICLOSAN

Date of publication: 25/10/2022

During the plenary meeting on 24-25 October 2022, the Scientific Committee on Consumer Safety (SCCS) presented its final opinion on the safety of Triclocarban and Triclosan as substances with potential endocrine disrupting properties in cosmetic products.

Read More »

services

CONTACT US

  • info@criticalcatalyst.com
  • +351 91 200 43 51
    PT mobile network call
  • EUROPEAN UNION (HQ)
    679 Avenida da República
    4450-242 Matosinhos (PT)
  • UNITED KINGDOM
    49 Queen Victoria Street
    EC4N 4SA London (UK)
Untitled design